“checkpoint-inhibitors” Archives

in
Entry Author Date Location
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
In Immuno-Oncology’s Latest Win, FDA OK’s Genentech Drug 05/18/16 San Francisco
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
Medical Test Validity Will Be Debated In 2016: 5 Storylines To Watch 01/14/16 Wisconsin
Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan 01/11/16 Boston
With New Startup, Caperna, Moderna Gets in on Cancer Vaccine Buzz 10/22/15 Boston
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
With $55M, Neon Wants To Make the Cancer Vaccine “Problem” Personal 10/01/15 Boston
Moving on From Sarepta, Krieg Lands at Cancer Startup Checkmate Pharma 08/12/15 Boston
XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease 06/11/15 Boston
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
Celldex Builds Case for Brain Cancer Vaccine With New ASCO Data 05/31/15 New York
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
Novartis Bets $250M-Plus on Aduro’s Immuno-Oncology Work 03/30/15 San Francisco
Yes to Flexus: The Science And Strategy Behind A Huge Biotech Return 02/26/15 San Francisco
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Any Given Cell: Can Biotech Pioneer Steve Fodor Do it Again? 02/13/15 San Francisco
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
Pioneer’s Lament: Lack of Checkpoint Immunotherapy For Blood Cancer 12/08/14 National
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet 10/23/14 New York
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth 06/18/14 San Francisco
Celldex, Bristol-Myers Cut Deal on Immuno-Oncology Combo Trial 05/14/14 New York
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal 03/17/14 San Francisco
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
East Coast Biotech Roundup: HART, CoStim, Forest/Actavis, & More 02/21/14 Boston
Page 2 of 2 « previous page